Selection of novel affinity-matured human chondroitin sulfate proteoglycan 4 antibody fragments by yeast display.

about

Selection of novel affinity-matured human chondroitin sulfate proteoglycan 4 antibody fragments by yeast display.

Item

http://www.wikidata.org/entity/Q47692413

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Selection of novel affinity-ma ...... dy fragments by yeast display.

@en

Selection of novel affinity-ma ...... dy fragments by yeast display.

@nl

type

Item

label

Selection of novel affinity-ma ...... dy fragments by yeast display.

@en

Selection of novel affinity-ma ...... dy fragments by yeast display.

@nl

prefLabel

Selection of novel affinity-ma ...... dy fragments by yeast display.

@en

Selection of novel affinity-ma ...... dy fragments by yeast display.

@nl

P1476

Selection of novel affinity-ma ...... dy fragments by yeast display.

@en

P2093

Liang Qu

http://www.w3.org/2001/XMLSchema#string

Vidyalakshmi Chandramohan

http://www.w3.org/2001/XMLSchema#string

Xin Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Cells and cell lysates: a direct approach for engineering antibodies against membrane proteins using yeast surface display

High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method

Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies.

Isolating and engineering human antibodies using yeast surface display.

Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4

Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells.

Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas

CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer

Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.

Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.

P304

639-647

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/PROTEIN/GZX038

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Darell D. Bigner

P577

2017-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28981720

http://www.w3.org/2001/XMLSchema#string

P932

5914443

http://www.w3.org/2001/XMLSchema#string